IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.040
-0.145 (-12.24%)
Aug 27, 2026, 10:53 AM EDT - Market open
IN8bio Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, IN8bio stock has a consensus rating of "Strong Buy" and an average price target of $6.25. The average 1-year stock price forecast is 500.96% higher than the current stock price, while the lowest is $4.00 (+284.62%) and the highest is $10 (+861.54%).
Price Target: $6.25 (+500.96%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IN8bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $4 | Buy | Maintains | $4 | +284.62% | Aug 12, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $5 | Buy | Maintains | $5 | +380.77% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +476.92% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
829.75K
EPS This Year
-1.09
from -4.44
EPS Next Year
-0.97
from -1.09
EPS and Forward PE are based on non-GAAP adjusted numbers.